| 產(chǎn)品編號 | bs-4814R-Gold |
| 英文名稱1 | Rabbit Anti-Newcastle disease virus/Gold Conjugated antibody |
| 中文名稱 | 膠體金標記的雞新城疫疫苗（雞瘟4型混合病毒）抗體 |
| 別 名 | Newcastle Disease Virus Ribonucleoprotein |
| 規(guī)格價格 | 100ul/2980元 購買 大包裝/詢價 |
| 說 明 書 | 100ul（10nm 15nm 35nm） |
| 研究領域 | 免疫學 細菌及病毒 |
| 抗體來源 | Rabbit |
| 克隆類型 | Polyclonal |
| 交叉反應 | |
| 產(chǎn)品應用 | IEM=1:20-200 ICA=1:20-200 ChIP=1:20-200
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 性 狀 | Lyophilized or Liquid |
| 濃 度 | 0.4mg/ml |
| 免 疫 原 | whole cell protein of New Castle disease |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 儲 存 液 | 0.02M TBS(pH8.2) with 1% BSA, 0.03% Proclin300. |
| 保存條件 | Store at 2-8 oC for 3-6 months. Avoid repeated freeze/thaw cycles. |
| 產(chǎn)品介紹 |
background: Newcastle Disease Virus (NDV), is a negative-sense single-stranded RNA virus. Transmission occurs by exposure to faecal and other excretions from infected birds, and through contact with contaminated feed, water, equipment and clothing. NDV strains can be categorised as velogenic (highly virulent), mesogenic (intermediate virulence) or lentogenic (nonvirulent). Velogenic strains produce severe nervous and respiratory signs, spread rapidly and cause up to 90% mortality. Mesogenic strains cause coughing, affect egg quality and production and result in up to 10% mortality. Lentogenic strains produce mild signs with negligible mortality. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 雞新城疫病毒由副粘病毒引起 雞新城疫 的高度接觸性傳染病。又稱亞洲雞瘟或偽雞瘟 。常呈急性敗血癥狀 。主要特征是呼吸困難、便稀、神經(jīng)紊亂、黏膜和漿膜出血。死亡率高，對養(yǎng)雞業(yè)危害嚴重。 速發(fā)嗜內(nèi)臟型新城疫(VVND；Doyle，1927)，可致所有年齡的雞發(fā)生最急性或急性、致死性疾病。通常見有消化道出血性病變。 雞新城疫 速發(fā)嗜肺腦型新城疫(VPND；Beach，1942)，可致所有年齡發(fā)生急性，通常是致死性疾病，以出現(xiàn)呼吸道和神經(jīng)癥狀為特征。 中發(fā)型新城疫(MND； Beaudette and Black，1946)，呼吸系統(tǒng)或神經(jīng)系統(tǒng)疾病的低致病性形式。死亡僅見于幼雛。 緩發(fā)型新城疫(LND；Hitchner 和Johnson，1948)，輕度或不顯性的呼吸道疾病。 無癥狀型或緩發(fā)嗜腸型新城疫 (LEND；Lancaster，1981)，主要是腸道感染。 |
| 1、抗體溶解方法 | |
| 2、抗體修復方式 | |
| 3、常用試劑的配制 | |
| 4、免疫組化操作步驟 | |
| 5、免疫組化問題解答 | |
| 6、Western Blotting 操作步驟 | |
| 7、Western Blotting 問題解答 | |
| 8、關于肽鏈的設計 | |
| 9、多肽的溶解與保存 | |
| 10、酶標抗體效價測定程序 | |
